| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 4, Issue 11 879-883, Copyright © 1993 by American Association of Cancer Research
ARTICLES |
AJ Wagner, C Meyers, LA Laimins and N Hay
Department of Biochemistry and Molecular Biology, University of Chicago, Illinois 60637.
The role of the product of the c-myc protooncogene in the regulation of cellular proliferation and differentiation is well established. Recent reports that c-Myc can serve as a sequence-specific transcriptional activator have begun to elucidate the mechanism by which c-Myc exerts such a profound effect on the mitotic status of a cell. To identify a potential target gene for Myc-mediated trans-activation, we examined the regulation of the ornithine decarboxylase (ODC) gene by c-Myc. ODC is the first and rate-limiting enzyme involved in the synthesis of the polyamines and has been shown to be required for entry into and progression through the cell cycle. Using a conditionally active c-Myc-estrogen receptor chimeric protein, we found estrogen-dependent activation of ODC expression and enzymatic activity. The induction of ODC mRNA expression was not dependent upon de novo protein synthesis. These data suggest that one downstream pathway for Myc-directed cell cycle control is the induction of ODC expression.
This article has been cited by other articles:
![]() |
W.-R. Liao, R.-H. Hsieh, K.-W. Hsu, M.-Z. Wu, M.-J. Tseng, R.-T. Mai, Y.-H. Wu Lee, and T.-S. Yeh The CBF1-independent Notch1 signal pathway activates human c-myc expression partially via transcription factor YY1 Carcinogenesis, September 1, 2007; 28(9): 1867 - 1876. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Saunders and E. Verdin Ornithine decarboxylase activity in tumor cell lines correlates with sensitivity to cell death induced by histone deacetylase inhibitors. Mol. Cancer Ther., November 1, 2006; 5(11): 2777 - 2785. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ozawa, M. Shichiri, N. Fukai, T. Yoshimoto, and Y. Hirata Regulation of Adrenomedullin Gene Transcription and Degradation by the c-myc Gene Endocrinology, September 1, 2004; 145(9): 4244 - 4250. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Datta, A. Nag, W. Pan, N. Hay, A. L. Gartel, O. Colamonici, Y. Mori, and P. Raychaudhuri Myc-ARF (Alternate Reading Frame) Interaction Inhibits the Functions of Myc J. Biol. Chem., August 27, 2004; 279(35): 36698 - 36707. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. McCaffrey, P. Fawcett, M. O'Riordan, K.-D. Lee, E. A. Havell, P. O. Brown, and D. A. Portnoy From the Cover: A specific gene expression program triggered by Gram-positive bacteria in the cytosol PNAS, August 3, 2004; 101(31): 11386 - 11391. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Satoh, I. Matsumura, H. Tanaka, S. Ezoe, H. Sugahara, M. Mizuki, H. Shibayama, E. Ishiko, J. Ishiko, K. Nakajima, et al. Roles for c-Myc in Self-renewal of Hematopoietic Stem Cells J. Biol. Chem., June 11, 2004; 279(24): 24986 - 24993. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Kramer, B.-D. Chang, Y. Chen, P. Diegelman, K. Alm, A. R. Black, I. B. Roninson, and C. W. Porter Polyamine Depletion in Human Melanoma Cells Leads to G1 Arrest Associated with Induction of p21WAF1/CIP1/SDI1, Changes in the Expression of p21-regulated Genes, and a Senescence-like Phenotype Cancer Res., November 1, 2001; 61(21): 7754 - 7762. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hermann, K. D. Berndt, and A. P. Wright How Transcriptional Activators Bind Target Proteins J. Biol. Chem., October 19, 2001; 276(43): 40127 - 40132. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Frank, M. Schroeder, P. Fernandez, S. Taubert, and B. Amati Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation Genes & Dev., August 15, 2001; 15(16): 2069 - 2082. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Conzen, K. Gottlob, E. S. Kandel, P. Khanduri, A. J. Wagner, M. O'Leary, and N. Hay Induction of Cell Cycle Progression and Acceleration of Apoptosis Are Two Separable Functions of c-Myc: Transrepression Correlates with Acceleration of Apoptosis Mol. Cell. Biol., August 15, 2000; 20(16): 6008 - 6018. [Abstract] [Full Text] |
||||
![]() |
S. K. Gilmour, M. Birchler, M. K. Smith, K. Rayca, and J. Mostochuk Effect of Elevated Levels of Ornithine Decarboxylase on Cell Cycle Progression in Skin Cell Growth Differ., November 1, 1999; 10(11): 739 - 748. [Abstract] [Full Text] |
||||
![]() |
I. Ben-Porath, O. Yanuka, and N. Benvenisty The Tmp Gene, Encoding a Membrane Protein, Is a c-Myc Target with a Tumorigenic Activity Mol. Cell. Biol., May 1, 1999; 19(5): 3529 - 3539. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. O. Mitchell and W. S. El-Deiry Overexpression of c-Myc Inhibits p21WAF1/CIP1 Expression and Induces S-Phase Entry in 12-O-Tetradecanoylphorbol-13-acetate (TPA)-sensitive Human Cancer Cells Cell Growth Differ., April 1, 1999; 10(4): 223 - 230. [Abstract] [Full Text] |
||||
![]() |
R. M. Ray, M. J. Viar, T. B. Patel, and L. R. Johnson Interaction of asparagine and EGF in the regulation of ornithine decarboxylase in IEC-6 cells Am J Physiol Gastrointest Liver Physiol, March 1, 1999; 276(3): G773 - G780. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Kramer, S. Vujcic, P. Diegelman, J. Alderfer, J. T. Miller, J. D. Black, R. J. Bergeron, and C. W. Porter Polyamine Analogue Induction of the p53-p21WAF1/CIP1-Rb Pathway and G1 Arrest in Human Melanoma Cells Cancer Res., March 1, 1999; 59(6): 1278 - 1286. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. V. Dang c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism Mol. Cell. Biol., January 1, 1999; 19(1): 1 - 11. [Full Text] [PDF] |
||||
![]() |
A. Bush, M. Mateyak, K. Dugan, A. Obaya, S. Adachi, J. Sedivy, and M. Cole c-myc null cells misregulate cad and gadd45 but not other proposed c-Myc targets Genes & Dev., December 15, 1998; 12(24): 3797 - 3802. [Abstract] [Full Text] |
||||
![]() |
E. M. Flinn, C. M. C. Busch, and A. P. H. Wright myc Boxes, Which Are Conserved in myc Family Proteins, Are Signals for Protein Degradation via the Proteasome Mol. Cell. Biol., October 1, 1998; 18(10): 5961 - 5969. [Abstract] [Full Text] |
||||
![]() |
G. L. Law, H. Itoh, D. J. Law, G. J. Mize, J. L. Merchant, and D. R. Morris Transcription Factor ZBP-89 Regulates the Activity of the Ornithine Decarboxylase Promoter J. Biol. Chem., August 7, 1998; 273(32): 19955 - 19964. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. Lee, L. Li, L. Philipson, and E. B. Ziff Myc represses transcription of the growth arrest gene gas1 PNAS, November 25, 1997; 94(24): 12886 - 12891. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shichiri, S. Adachi, J. M. Sedivy, F. Marumo, and Y. Hirata Biphasic Regulation of the Preproendothelin-1 Gene by c-myc Endocrinology, November 1, 1997; 138(11): 4584 - 4590. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pietila, L. Alhonen, M. Halmekyto, P. Kanter, J. Janne, and C. W. Porter Activation of Polyamine Catabolism Profoundly Alters Tissue Polyamine Pools and Affects Hair Growth and Female Fertility in Transgenic Mice Overexpressing Spermidine/Spermine N1-Acetyltransferase J. Biol. Chem., July 25, 1997; 272(30): 18746 - 18751. [Abstract] [Full Text] [PDF] |
||||
![]() |
P J Hurlin, C Queva, and R N Eisenman Mnt, a novel Max-interacting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites. Genes & Dev., January 1, 1997; 11(1): 44 - 58. [Abstract] [PDF] |
||||
![]() |
A. Eden, G. Simchen, and N. Benvenisty Two Yeast Homologs of ECA39, a Target for c-Myc Regulation, Code for Cytosolic and Mitochondrial Branched-chain Amino Acid Aminotransferases J. Biol. Chem., August 23, 1996; 271(34): 20242 - 20245. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Desbarats, S Gaubatz, and M Eilers Discrimination between different E-box-binding proteins at an endogenous target gene of c-myc. Genes & Dev., February 15, 1996; 10(4): 447 - 460. [Abstract] [PDF] |
||||
![]() |
A J Wagner, J M Kokontis, and N Hay Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1. Genes & Dev., December 1, 1994; 8(23): 2817 - 2830. [Abstract] [PDF] |
||||
![]() |
A. L. Gartel, X. Ye, E. Goufman, P. Shianov, N. Hay, F. Najmabadi, and A. L. Tyner Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3 PNAS, April 10, 2001; 98(8): 4510 - 4515. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |